BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 76 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $573,338 | -34.5% | 123,034 | -28.7% | 0.00% | 0.0% |
Q1 2024 | $875,229 | +566.8% | 172,629 | +269.6% | 0.00% | – |
Q4 2023 | $131,255 | +1467.2% | 46,710 | +1500.8% | 0.00% | – |
Q3 2023 | $8,375 | -92.8% | 2,918 | -87.3% | 0.00% | – |
Q2 2023 | $115,665 | +261.5% | 22,904 | +21.7% | 0.00% | – |
Q3 2022 | $32,000 | -34.7% | 18,813 | -6.0% | 0.00% | – |
Q2 2022 | $49,000 | -80.1% | 20,012 | -0.9% | 0.00% | -100.0% |
Q2 2021 | $246,000 | – | 20,189 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |